NASDAQ: OKYOOkyo Pharma Ltd Stock Ownership - Who owns Okyo Pharma?
Insider buying vs selling
Have Okyo Pharma Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Rajkumar V. Patil | CSci | 2026-07-27 | 3,363 | $1.49 | $5.01kBuy |
| Rajkumar V. Patil | CSci | 2026-07-27 | 3,363 | $1.49 | $5.01kBuy |
| Robert John Dempsey | CEO | 2026-07-22 | 15,000 | $1.54 | $23.09kBuy |
| Robert John Dempsey | CEO | 2026-07-22 | 15,000 | $1.54 | $23.09kBuy |
| Flavio Mantelli | Med | 2026-07-21 | 20,000 | $1.40 | $28.00kBuy |
| Gabriele M. Cerrone | Director | 2026-07-21 | 22,500 | $1.45 | $32.63kBuy |
| Gabriele M. Cerrone | Director | 2026-07-21 | 22,500 | $1.45 | $32.63kBuy |
| John P. Brancaccio | Director | 2026-07-21 | 5,000 | $1.48 | $7.39kBuy |
| John P. Brancaccio | Director | 2026-07-21 | 5,000 | $1.48 | $7.39kBuy |
| Gary S. Jacob | CXO | 2026-07-21 | 3,500 | $1.40 | $4.90kBuy |
OKYO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OKYO insiders and whales buy or sell their stock.
OKYO Shareholders
What type of owners hold Okyo Pharma Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gabriele M. Cerrone | 1,075.81% | 564,581,547 | $745.25M | Insider |
| Gary S. Jacob | 0.21% | 112,420 | $148.39k | Insider |
| John P. Brancaccio | 0.07% | 35,201 | $46.47k | Insider |
| Flavio Mantelli | 0.04% | 20,000 | $26.40k | Insider |
| Keeren Rameshchandra Shah | 0.03% | 16,667 | $22.00k | Insider |
| Rajkumar V. Patil | 0.03% | 16,667 | $22.00k | Insider |
| Willy Jules Simon | 0.03% | 15,383 | $20.31k | Insider |
| Robert John Dempsey | 0.03% | 15,000 | $19.80k | Insider |
| Woodli | 0.01% | 3,653 | $4.82k | Institution |
| Woodline Partners LP | 0.01% | 3,652 | $4.82k | Institution |
OKYO vs Biotech Stocks
Okyo Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.